Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 14:25:e45233.
doi: 10.2196/45233.

Challenges in Using mHealth Data From Smartphones and Wearable Devices to Predict Depression Symptom Severity: Retrospective Analysis

Affiliations

Challenges in Using mHealth Data From Smartphones and Wearable Devices to Predict Depression Symptom Severity: Retrospective Analysis

Shaoxiong Sun et al. J Med Internet Res. .

Abstract

Background: Major depressive disorder (MDD) affects millions of people worldwide, but timely treatment is not often received owing in part to inaccurate subjective recall and variability in the symptom course. Objective and frequent MDD monitoring can improve subjective recall and help to guide treatment selection. Attempts have been made, with varying degrees of success, to explore the relationship between the measures of depression and passive digital phenotypes (features) extracted from smartphones and wearables devices to remotely and continuously monitor changes in symptomatology. However, a number of challenges exist for the analysis of these data. These include maintaining participant engagement over extended time periods and therefore understanding what constitutes an acceptable threshold of missing data; distinguishing between the cross-sectional and longitudinal relationships for different features to determine their utility in tracking within-individual longitudinal variation or screening individuals at high risk; and understanding the heterogeneity with which depression manifests itself in behavioral patterns quantified by the passive features.

Objective: We aimed to address these 3 challenges to inform future work in stratified analyses.

Methods: Using smartphone and wearable data collected from 479 participants with MDD, we extracted 21 features capturing mobility, sleep, and smartphone use. We investigated the impact of the number of days of available data on feature quality using the intraclass correlation coefficient and Bland-Altman analysis. We then examined the nature of the correlation between the 8-item Patient Health Questionnaire (PHQ-8) depression scale (measured every 14 days) and the features using the individual-mean correlation, repeated measures correlation, and linear mixed effects model. Furthermore, we stratified the participants based on their behavioral difference, quantified by the features, between periods of high (depression) and low (no depression) PHQ-8 scores using the Gaussian mixture model.

Results: We demonstrated that at least 8 (range 2-12) days were needed for reliable calculation of most of the features in the 14-day time window. We observed that features such as sleep onset time correlated better with PHQ-8 scores cross-sectionally than longitudinally, whereas features such as wakefulness after sleep onset correlated well with PHQ-8 longitudinally but worse cross-sectionally. Finally, we found that participants could be separated into 3 distinct clusters according to their behavioral difference between periods of depression and periods of no depression.

Conclusions: This work contributes to our understanding of how these mobile health-derived features are associated with depression symptom severity to inform future work in stratified analyses.

Keywords: behavioral patterns; depression; digital phenotypes; missing data; mobile health; mobile phone; smartphones; wearable devices.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: SV and VAN are employees of Janssen Research and Development LLC. PA is employed by the pharmaceutical company H Lundbeck A/S. DCM has accepted honoraria and consulting fees from Otsuka Pharmaceuticals Co, Ltd; Optum Behavioral Health; Centerstone Research Institute; and the One Mind Foundation; has received royalties from Oxford Press; and has an ownership interest in Adaptive Health, Inc. MH is the principal investigator of Remote Assessment of Disease and Relapse–Central Nervous System (RADAR-CNS), a private-public precompetitive consortium that receives funding from Janssen Research and Development LLC, UCB, H Lundbeck A/S, MSD, and Biogen. All other authors declare no other conflicts of interest.

Figures

Figure 1
Figure 1
Sleep duration from 4 random participants. Weekend 0 and 1 (denoted by color only) are weekdays and weekends, respectively. The 8-item Patient Health Questionnaire depression (PHQ-8) scale order j=1, 2, 3, 4 (denoted by marker only) represents the j-th 14-day period (before the PHQ-8 assessment) having the same PHQ-8 scores. Mean and median were calculated within the same PHQ-8 score.
Figure 2
Figure 2
(A) Explained variance ratio in the principal component analysis on the processed behavioral difference (quantified by the features) between periods of high and low 8-item Patient Health Questionnaire depression scale scores. (B) Silhouette coefficients in the clustering analysis using the Gaussian mixture model.
Figure 3
Figure 3
Parallel plot for the mean and SD of the identified 3 clusters after standardization. WASF: wakefulness after sleep offset.

Similar articles

Cited by

References

    1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey Replication The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003 Jun 18;289(23):3095–105. doi: 10.1001/jama.289.23.3095.289/23/3095 - DOI - PubMed
    1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593–602. doi: 10.1001/archpsyc.62.6.593.62/6/593 - DOI - PubMed
    1. Martin JK, Blum TC, Beach SR, Roman PM. Subclinical depression and performance at work. Soc Psychiatry Psychiatr Epidemiol. 1996 Jan;31(1):3–9. doi: 10.1007/BF00789116. - DOI - PubMed
    1. Wells KB, Miranda J, Bauer MS, Bruce ML, Durham M, Escobar J, Ford D, Gonzalez J, Hoagwood K, Horwitz SM, Lawson W, Lewis L, McGuire T, Pincus H, Scheffler R, Smith WA, Unützer J. Overcoming barriers to reducing the burden of affective disorders. Biol Psychiatry. 2002 Sep 15;52(6):655–75. doi: 10.1016/s0006-3223(02)01403-8.S0006322302014038 - DOI - PubMed
    1. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res. 2003;12(1):22–33. doi: 10.1002/mpr.139. https://europepmc.org/abstract/MED/12830307 - DOI - PMC - PubMed

Publication types